Med-X, Inc. plans to list on the Nasdaq under the symbol MXRX. It filed a Form S-1 registration statement for an initial public offering on September 25, 2026. As of November 4, 2026, its registration is amended and on file (Form S-1/A, October 29, 2026).
Sell to companies like Med-X, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
Med-X, Inc. filed a Form S-1 registration statement for an initial public offering on 2026-09-25. It has amended it 2 times. As of its latest filing, on 2026-10-29, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.
Also on the record for Med-X, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 15, 2025 | Crowdfunding filing, Form C-U | $5K target | Crowdfunding | Source |
| September 27, 2024 | Crowdfunding filing, Form C/A | $5K target | Crowdfunding | Source |
| July 10, 2024 | Crowdfunding filing, Form C/A | $5K target | Crowdfunding | Source |
Check before you invest in Med-X, Inc.: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on Med-X, Inc. and the records around it.
Med-X, Inc. elsewhere on the record
- Crowdfunding filing Apr 2025
Also filing to list on the Nasdaq
IPO filings on the Nasdaq in Q4 2026, newest first.
- Parabolic Technologies, Inc. (Oct 2026)
- DataMeds AI, Inc. (Oct 2026)
Watch Med-X, Inc.
Get an email when Med-X, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Med-X, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Med-X, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Med-X, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
What the filings say
Listing
We have applied for the listing of our common stock under the symbol “MXRX” on NASDAQ.From the S-1/A filed 2026-10-29
Revenue
For the year ended December 31, 2025 we had net revenues of $1,987,181 compared to $1,730,284 for the year ended December 31, 2024 reflecting a slight increase period over period.From the S-1/A filed 2026-10-29
Net loss or income
Net loss for the three months ended June 30, 2026, was $1,207,882 compared to $3,153,668 for the three months ended June 30, 2025.From the S-1/A filed 2026-10-29
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2026-09-25 | Registration statement filed | S-1 |
| 2026-10-15 | Registration statement amended | S-1/A |
| 2026-10-29 | Registration statement amended | S-1/A |
Tools for this story
Each opens in a new tab, filled in for Med-X, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.